Rodent breeding, preclinical testing facility to be set up

GVSAP to invest $5 m for the unit in Genome Valley

May 31, 2022 11:49 pm | Updated 11:49 pm IST - HYDERABAD

Preclinical research products and services provider GV Safety Assessment Platform (GVSAP) will be setting up a rodent breeding and preclinical testing facility in Genome Valley, Hyderabad.

The investment, on the 28,000 sq.ft. facility to support commercial SPF breeding, will be $5 million over the next three years, GVSAP said, also announcing a strategic supply partnership with Envigo RMS LLC, a leading global supplier of research models and associated services.

The companies have entered into a definitive agreement that authorises GVSAP to commercially breed select rodent models and distribute Envigo’s RMS product and service portfolio in India. Their partnership will cater to the high demand for research models in Indian market across sectors such as vaccines, pharma, biologics and medical devices.

Initially, the facility at Genome Valley will breed selected traditional and immunocompromised rodent strains that are in high demand. The company will be the distributor for Envigo’s products and services in India, GVSAP said in a release.

Top News Today

Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in


Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.